4//SEC Filing
GALLAHUE KIERAN 4
Accession 0001562180-22-004073
CIK 0001271214other
Filed
May 15, 8:00 PM ET
Accepted
May 16, 6:39 PM ET
Size
36.5 KB
Accession
0001562180-22-004073
Insider Transaction Report
Form 4
Gallahue Kieran
Director
Transactions
- Disposition from Tender
Common Stock
2022-05-13$28.25/sh−3,239$91,502→ 5,011 total - Disposition from Tender
Common Stock
2022-05-13$28.25/sh−5,011$141,561→ 0 total - Disposition from Tender
Stock Option (right to buy)
2022-05-13$28.25/sh−3,390$95,768→ 0 totalExercise: $21.00Exp: 2031-03-15→ Common Stock (3,390 underlying) - Disposition from Tender
Stock Option (right to buy)
2022-05-13$28.25/sh−82,387$2,327,433→ 0 totalExercise: $17.01Exp: 2029-09-29→ Common Stock (82,387 underlying) - Disposition from Tender
Stock Option (right to buy)
2022-05-13$28.25/sh−5,734$161,986→ 0 totalExercise: $16.50Exp: 2031-06-02→ Common Stock (5,734 underlying) - Disposition from Tender
Stock Option (right to buy)
2022-05-13$28.25/sh−9,666$273,065→ 0 totalExercise: $11.84Exp: 2030-06-03→ Common Stock (9,666 underlying) - Disposition from Tender
Stock Options (Right to buy)
2022-05-13$28.25/sh−3,473$98,112→ 0 totalExercise: $42.05Exp: 2028-06-04→ Common Stock (3,473 underlying) - Disposition from Tender
Stock Option (right to buy)
2022-05-13$28.25/sh−12,500$353,125→ 0 totalExercise: $13.79Exp: 2026-06-01→ Common Stock (12,500 underlying) - Disposition from Tender
Stock Options (Right to buy)
2022-05-13$28.25/sh−6,035$170,489→ 0 totalExercise: $26.05Exp: 2027-05-31→ Common Stock (6,035 underlying) - Disposition from Tender
Stock Options (Right to buy)
2022-05-13$28.25/sh−25,000$706,250→ 0 totalExercise: $25.31Exp: 2025-04-07→ Common Stock (25,000 underlying) - Disposition from Tender
Common Stock
2022-05-13$28.25/sh−29,262$826,652→ 0 total(indirect: See Footnote) - Disposition from Tender
Stock Option (right to buy)
2022-05-13$28.25/sh−120,064$3,391,808→ 0 totalExercise: $25.10Exp: 2029-05-06→ Common Stock (120,064 underlying) - Disposition from Tender
Stock Options (Right to buy)
2022-05-13$28.25/sh−13,248$374,256→ 0 totalExercise: $13.05Exp: 2027-01-17→ Common Stock (13,248 underlying)
Footnotes (4)
- [F1]Pursuant to the Merger Agreement, at the Effective Time, each restricted stock unit that was subject to vesting conditions based solely on continued employment with or service to the Company or any of its subsidiaries (each, an 'Issuer RSU') that was outstanding and unvested immediately prior to the Effective Time was cancelled and automatically converted into the right to receive an amount in cash equal to the product of (1) the aggregate number of Issuer Common Stock subject to such Issuer RSU and (2) the Common Stock Merger Consideration, subject to any required withholding of taxes.
- [F2]Reflects disposition of Issuer common stock in connection with the consummation of the transactions contemplated by the Agreement and Plan of Merger (the 'Merger Agreement'), dated August 6, 2021, by and among the Issuer, Medtronic, Inc. ('Parent') and Project Kraken Merger Sub, Inc., a wholly-owned subsidiary of Parent ('Merger Sub'), including the consummation of the merger (the 'Merger') between Issuer and Merger Sub on May 13, 2022. Pursuant to the Merger Agreement, as of the effective time of the Merger (the 'Effective Time'), [each outstanding share of Issuer common stock, $0.001 par value per share ('Issuer Common Stock'), was cancelled, retired and converted into the right to receive an amount equal to $28.25 in cash, without interest thereon (the 'Common Stock Merger Consideration'), subject to any required withholding of taxes].
- [F3]The reportable securities are held by the Gallahue Irrevocable Trust.
- [F4]Pursuant to the Merger Agreement, at the Effective Time, each option granted by the Issuer to purchase Issuer Common Stock other than options subject to performance-based vesting conditions (each, an 'Issuer Option') that was outstanding and unexercised as of immediately prior to the Effective Time was cancelled and automatically converted into the right to receive an amount in cash equal to the product of (1) the aggregate number of Issuer Common Stock subject to such Issuer Option and (2) the excess, if any, of the Common Stock Merger Consideration over the exercise price of such Issuer Option, subject to any required withholding of taxes.
Issuer
Intersect ENT, Inc.
CIK 0001271214
Entity typeother
Related Parties
1- filerCIK 0001308428
Filing Metadata
- Form type
- 4
- Filed
- May 15, 8:00 PM ET
- Accepted
- May 16, 6:39 PM ET
- Size
- 36.5 KB